BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33184434)

  • 1. Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers.
    Kerschbaum J; Rudnicki M; Dzien A; Dzien-Bischinger C; Winner H; Heerspink HL; Rosivall L; Wiecek A; Mark PB; Eder S; Denicolò S; Mayer G
    Sci Rep; 2020 Nov; 10(1):19743. PubMed ID: 33184434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
    Ihara K; Skupien J; Kobayashi H; Md Dom ZI; Wilson JM; O'Neil K; Badger HS; Bowsman LM; Satake E; Breyer MD; Duffin KL; Krolewski AS
    Diabetes Care; 2020 Nov; 43(11):2760-2767. PubMed ID: 32887710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Bringans SD; Lipscombe RJ; Davis TME
    J Diabetes Complications; 2019 Dec; 33(12):107406. PubMed ID: 31669066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biomarkers for prognosticating diabetic kidney disease progression.
    Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
    Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of diabetic kidney disease.
    Colhoun HM; Marcovecchio ML
    Diabetologia; 2018 May; 61(5):996-1011. PubMed ID: 29520581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
    Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
    Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate.
    Leong A; Ekinci EI; Nguyen C; Milne M; Hachem M; Dobson M; MacIsaac RJ; Jerums G
    BMC Nephrol; 2017 Dec; 18(1):355. PubMed ID: 29207965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K; Imamura M; Yamaguchi S; Teshigawara S; Tone A; Uchida HA; Eguchi J; Nakatsuka A; Ogawa D; Yoshida M; Yamada M; Shikata K; Wada J
    Diabetes Care; 2018 Aug; 41(8):1765-1775. PubMed ID: 29930140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
    Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
    JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
    Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
    J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study.
    El Ghormli L; Wen H; Uschner D; Haymond MW; Hughan KS; Kutney K; Laffel L; Tollefsen SE; Escaname EN; Lynch J; Bjornstad P;
    Pediatr Nephrol; 2023 Dec; 38(12):4137-4144. PubMed ID: 37434027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
    Pichaiwong W; Homsuwan W; Leelahavanichkul A
    Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.